1. Home
  2. JAGX vs KXIN Comparison

JAGX vs KXIN Comparison

Compare JAGX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • KXIN
  • Stock Information
  • Founded
  • JAGX 2013
  • KXIN 2015
  • Country
  • JAGX United States
  • KXIN China
  • Employees
  • JAGX N/A
  • KXIN N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • JAGX Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • JAGX 3.1M
  • KXIN 2.8M
  • IPO Year
  • JAGX N/A
  • KXIN N/A
  • Fundamental
  • Price
  • JAGX $4.55
  • KXIN $0.88
  • Analyst Decision
  • JAGX
  • KXIN
  • Analyst Count
  • JAGX 0
  • KXIN 0
  • Target Price
  • JAGX N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • KXIN 90.7K
  • Earning Date
  • JAGX 03-31-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • JAGX N/A
  • KXIN N/A
  • EPS Growth
  • JAGX N/A
  • KXIN N/A
  • EPS
  • JAGX N/A
  • KXIN N/A
  • Revenue
  • JAGX $11,689,000.00
  • KXIN N/A
  • Revenue This Year
  • JAGX $18.18
  • KXIN N/A
  • Revenue Next Year
  • JAGX $40.06
  • KXIN N/A
  • P/E Ratio
  • JAGX N/A
  • KXIN N/A
  • Revenue Growth
  • JAGX 19.75
  • KXIN N/A
  • 52 Week Low
  • JAGX $4.40
  • KXIN $0.80
  • 52 Week High
  • JAGX $540.00
  • KXIN $29.52
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.14
  • KXIN 22.49
  • Support Level
  • JAGX $4.41
  • KXIN $0.90
  • Resistance Level
  • JAGX $4.97
  • KXIN $0.96
  • Average True Range (ATR)
  • JAGX 0.83
  • KXIN 0.07
  • MACD
  • JAGX 0.16
  • KXIN 0.00
  • Stochastic Oscillator
  • JAGX 1.86
  • KXIN 28.39

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: